Skip to content

Loading your page…

Pharmaceutical group

Centocor

6 medicines2 countries

A group of 4 companies with 6 medicines in 2 countries.

Group structure

4 companies in 1 country

United States2

Headquarters not stated2

Centocor B.V.Authorisation holder · 1 medicine · listed in Canada, the EU (EMA)
Centocor Ortho Biotech Products, L.P.Authorisation holder · 1 medicine · listed in Brazil, United States

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

6 medicines

Medicine	Substance	Country	Status	Authorised
MYOSCINTVial	Imciromab pentetate n/a	United States	Not marketed	1996
REMICADE100mg · Vial	Infliximab	United States	Marketed	1998
REOPRO2mg/ml · Injectable	Abciximab	United States	Marketed	1994
SIMPONI50mg · Injectable	Golimumab	United States	Marketed	2009
Orthoclone OKT31mg/ml · Injection	Muromonab-cd3	United States	Withdrawn	1992
Sovrima	Idebenone	EU (EMA)	Refused

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	5	4	1	Companies All medicines
European Union (EMA)	1	0	1	Companies All medicines

Also in the registers of Brazil, Canada